SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead Vt Regulatory News (BVT)

Share Price Information for Baronsmead Vt (BVT)

Share Price is delayed by 15 minutes
Get Live Data
45.00    0.00 (0.00%)
Bid:
44.00
Ask:
46.00
Spread: 2.00 (4.545%)
Market Cap: £203.60m
BVT Live PriceLast checked at - London Stock Exchange

Intraday Baronsmead Vt Share Chart

Offer for Subscription - Update

6 Nov 2017 11:15

RNS Number : 6578V
Baronsmead Venture Trust PLC
06 November 2017
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR ANY JURISDICTION IN WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA.

BARONSMEAD VENTURE TRUST PLC

6 November 2017

Offer For Subscription - Update

On 4 October 2017 Baronsmead Venture Trust plc (the "Company") launched an offer for subscription to raise up to £21 million (the "Offer"). The Offer was open exclusively to satisfy subscriptions from Existing Shareholders until 16 October 2017 and was then open to all investors. The Company issued 19,228,312 New Shares at an issue price of 94.80 pence on 26 October 2017 under the Offer.

The directors of the Company have been advised that, on the basis of Subscription Forms received during the course of 3 November 2017, the Offer has become fully subscribed. In accordance with the terms of the Offer investors whose Subscription Forms are received after this time will have their Subscription automatically allocated to the Baronsmead Second Venture Trust plc offer for subscription, which remains open, unless the investor has specifically stipulated on the Subscription Form that they do not want this to happen.

A further announcement in relation to the second allotment of New Shares under the Offer will be made shortly.

Definitions

Terms defined in the Prospectus have the same meanings in this announcement unless the context requires otherwise.

Further information

For further information please contact.

Michael Probin - VCT investor relations

Livingbridge VC LLP

020 7506 5796

Notes

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

The issue and the distribution of this announcement and the Prospectus in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to in this announcement and the Prospectus comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OUPEAFFKEFEXFFF
Date   Source Headline
27th Oct 20231:30 pmRNSNet Asset Value(s)
19th Oct 20234:51 pmRNSDirectorate Change
12th Oct 202311:22 amRNSAppointment of Non-Executive Director
2nd Oct 20234:00 pmRNSTotal Voting Rights
28th Sep 20235:52 pmRNSTransaction in Own Shares
12th Sep 20236:28 pmRNSTransaction in Own Shares - Replacement
12th Sep 20235:20 pmRNSTransaction in Own Shares
5th Sep 202311:00 amRNSIntention to Fundraise
4th Aug 20234:00 pmRNSNet Asset Value(s)
1st Aug 20231:52 pmRNSTotal Voting Rights
27th Jul 20234:11 pmRNSTransaction in Own Shares
24th Jul 20232:00 pmRNSNet Asset Value(s)
3rd Jul 202311:26 amRNSTotal Voting Rights
20th Jun 20233:45 pmRNSTransaction in Own Shares
13th Jun 20237:00 amRNSHalf-yearly Report
6th Jun 20235:30 pmRNSNet Asset Value(s)
12th May 20237:00 amRNSCompliance with the Market Abuse Regulation
5th May 20235:30 pmRNSNet Asset Value(s)
4th May 20231:00 pmRNSNet Asset Value(s)
2nd May 202312:57 pmRNSTotal Voting Rights
5th Apr 20236:21 pmRNSTransaction in Own Shares
3rd Apr 20233:47 pmRNSAllotment of Shares
3rd Apr 202311:09 amRNSTotal Voting Rights
30th Mar 202312:00 pmRNSNet Asset Value(s)
14th Mar 20234:54 pmRNSDirector/PDMR Shareholding
14th Mar 20234:27 pmRNSAllotment of Shares
10th Mar 20239:57 amRNSUpdate on Fundraising
9th Mar 20236:26 pmRNSTransaction in Own Shares
6th Mar 20234:45 pmRNSNet Asset Value(s)
1st Mar 20232:22 pmRNSTotal Voting Rights
22nd Feb 20237:00 amRNSUpdate on Fundraising
14th Feb 20237:00 amRNSTransaction in Own Shares
6th Feb 20235:00 pmRNSNet Asset Value(s)
1st Feb 20233:54 pmRNSResult of AGM
30th Jan 20235:30 pmRNSDirector/PDMR Shareholding
30th Jan 20235:28 pmRNSDirector/PDMR Shareholding
30th Jan 20235:23 pmRNSDirector/PDMR Shareholding
30th Jan 20233:07 pmRNSAllotment of Shares
27th Jan 202311:30 amRNSNet Asset Value(s)
3rd Jan 20234:49 pmRNSTotal Voting Rights
29th Dec 20224:56 pmRNSTransaction in Own Shares
16th Dec 202212:45 pmRNSPublication of a Prospectus
12th Dec 20224:37 pmRNSTransaction in Own Shares
6th Dec 20225:30 pmRNSNet Asset Value(s)
2nd Dec 20227:00 amRNSAnnual Financial Report
7th Nov 202211:30 amRNSNet Asset Value(s)
14th Oct 20224:45 pmRNSNet Asset Value(s)
3rd Oct 20227:00 amRNSTotal Voting Rights
29th Sep 20226:03 pmRNSTransaction in Own Shares
13th Sep 20226:08 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.